I am thinking about using anti-CXCL12 aptamer (NOX-A12) as targeting moeity in drug delivery system. This RNA aptamer has structural configuration of unnatural L-ribose nucleotides. If I use the similar sequence of natural D-ribose nucleotides of that aptamer, does it still maintain the high affinity to CXCL12 target?